NCT04817722

Brief Summary

The purpose of this retrospective study was to analyze the role of intraoperative crystalloid administration on postoperative hospital length of stay and on the incidence of previously reported adverse events following thoracic surgery.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

March 23, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 26, 2021

Completed
Last Updated

March 26, 2021

Status Verified

March 1, 2021

Enrollment Period

1.1 years

First QC Date

March 23, 2021

Last Update Submit

March 23, 2021

Conditions

Hospital Length of Stay; Adverse Events

Outcome Measures

Primary Outcomes (1)

  • Hospital Length of Stay

    Hospital Length of Stay

    30 days

Interventions

Intravenous SolutionDRUG

Intraoperative hydration

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients 18 years of age or older who required thoracic surgery.

You may qualify if:

  • All patients requiring thoracic surgery

You may not qualify if:

  • Patients less than 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Bobby D Nossaman, MD

    Ochsner Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2021

First Posted

March 26, 2021

Study Start

December 12, 2014

Primary Completion

January 31, 2016

Study Completion

June 1, 2016

Last Updated

March 26, 2021

Record last verified: 2021-03